Európska únia - slovenčina - EMA (European Medicines Agency)

mylan ireland limited - abiraterón acetátu - prostatické nádory - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Európska únia - slovenčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterón acetátu - prostatické nádory - endokrinná terapia - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Európska únia - slovenčina - EMA (European Medicines Agency)

bayer ag  - octocog alfa - hemofília a - antihemoragiká - liečba a profylaxia krvácania u pacientov s hemofíliou a (vrodená deficiencia faktora viii). tento prípravok neobsahuje von willebrand faktor, a preto nie je uvedené v von willebrand choroba.

Európska únia - slovenčina - EMA (European Medicines Agency)

krka, d.d., novo mesto - abiraterón acetátu - prostatické nádory - endokrinná terapia - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Európska únia - slovenčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - antitrombotické činidlá - prevention of venous thromboembolic events.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

orion corporation, fínsko - warfarín - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

orion corporation, fínsko - warfarín - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pro.med.cs praha a.s., Česká republika - warfarín - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pro.med.cs praha a.s., Česká republika - warfarín - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Európska únia - slovenčina - EMA (European Medicines Agency)

baxter holding b.v. - hydrochlorid doxorubicínu - sarcoma, kaposi; multiple myeloma; ovarian neoplasms; breast neoplasms - antineoplastické činidlá - caelyx pegylated liposomal je uvedené:ako monotherapy pre pacientov s metastatického karcinómu prsníka, tam, kde je zvýšené riziko srdcového;na liečbu pokročilej rakoviny vaječníkov u žien, ktorí neuspeli v prvom riadku platinum-založené chemoterapia režim;v kombinácii s bortezomib na liečbu progresívneho myelómom je mladších u pacientov, ktorí dostali aspoň jeden pred terapiou a ktorí už podstúpili alebo sú nevhodné pre kostnej drene sa transplantácia;pre liečbu aids súvisiace s kaposiho sarkóm (ks) u pacientov s nízkym počtom cd4 (.